Join to View Full Profile
104 Innovation DriveSuite 2000Greenville, SC 29607
Phone+1 864-603-6300
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Xuezhong Yang is an oncologist based in Greenville, SC, who completed his education including a fellowship in Medical Oncology and Hematology at Georgetown University Hospital, after graduating from China Medical University Shenyang. He has a substantial publication record in reputable journals and his research is widely cited, suggesting his contributions are well-recognized in the field of oncology. Notably, he has received an award for CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR by Epic Systems Corporation.
Education & Training
MedStart Georgetown University HospitalFellowship, Medical Oncology, 2010 - 2012- MedStart Georgetown University HospitalFellowship, Hematology, 2010 - 2012
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2006 - 2009
China Medical University ShenyangClass of 1995
Certifications & Licensure
SC State Medical License 2012 - 2027
DC State Medical License 2006 - 2016
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 147 citationsCarfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autolog...Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander
The Lancet. Oncology. 2020-10-01 - 191 citationsActivity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.Arthur E. Frankel, Jung H. Woo, Chul Ahn, Naveen Pemmaraju, Bruno C. Medeiros
Blood. 2014-07-17 - 4 citationsMaintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study.Benjamin A. Weinberg, Hongkun Wang, Xuezhong Yang, Christina Wu, Michael J. Pishvaian
Gastrointestinal Cancer Research. 2014-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
